| abstract |
The invention relates to a composition for use in the treatment, in particular symptomatic treatment, of n- mental disorder, preferably psychosis and/or depression, nand/or n- drug addiction, preferably nicotine addiction and/or tetrahydrocannabinol addiction, nand/or n- sleep disorder nand/or n- pain, nwherein the composition comprises tobacco and cannabidiol or tobacco and cannabis comprising cannabidiol and the composition is prepared for an inhalative administration. n Further, the invention relates to a smokable product for use in the treatment, in particular symptomatic treatment, of n- mental disorder, preferably psychosis and/or depression, nand/or n- drug addiction, preferably nicotine addiction and/or tetrahydrocannabinol addiction, nand/or n- sleep disorder nand/or n- pain, nwherein the smokable product comprises or consists of the composition. |